Dr. Berglund Presents at MDF Annual Conference

RNA Institute Director, Dr. Andrew Berglund, is attending the Myotonic Dystrophy Foundation’s 2018 Annual Conference on September 14-15 to present new research with clinical significance for myotonic dystrophy (DM) therapies. Dr. Berglund will be presenting his lab’s progress on developing new tools for studying myotonic dystrophy type 2 and the identification of small molecules that show promise as lead molecules for myotonic dystrophy type I and type 2.

A recent article from the lab describing the lab’s research on myotonic dystrophy and the MDF Annual Conference can be found below:



Go Back to Top ↑